Company Filing History:
18 out of 26 
2 out of 13 
1 out of 3 Years Active: 2002-2015
Title: Innovations and Contributions of Petr Kuzma in Medical Device Patents
Introduction
Petr Kuzma, a prolific inventor based in Princeton, NJ, has made significant contributions to the field of medical implant devices. With a remarkable portfolio of 22 patents, he has focused on innovations that enhance the biocompatibility and functionality of implantable devices.
Latest Patents
Among Kuzma's latest patents are groundbreaking inventions such as "Implant Device Release Agents and Methods of Using Same" and "Implantable Device for the Delivery of Risperidone and Methods of Use Thereof." The former pertains to the preparation of medical implant devices made from a polymeric material combined with a release agent. This release agent, characterized by a molecular weight of at least 1000, includes non-ionic surfactants like Brij 35 and Tween compounds. The devices aim to achieve optimal performance through improved hydration properties. The latter patent introduces a polyurethane-based polymer for delivering the biologically active drug risperidone, demonstrating high biocompatibility and stability, making it suitable for use in both human and animal patients.
Career Highlights
Kuzma has honed his expertise while working with notable companies in the pharmaceutical sector, including Endo Pharmaceuticals Solutions Inc. and Indevus Pharmaceuticals, Inc. His experience in these organizations has likely played a crucial role in his innovative contributions to medical device technology.
Collaborations
Throughout his career, Kuzma has collaborated with esteemed professionals, including Harry Quandt and Stefanie Decker. These partnerships have contributed to the successful development and commercialization of his inventive solutions within the medical field.
Conclusion
Petr Kuzma's innovative work in the realm of medical implant devices showcases his dedication to improving patient care through technology. With 22 patents under his name, he continues to lead advancements that benefit both human and animal patients, solidifying his status as a prominent figure in the field of medical innovations.